Enasidenib mesylate
| CAS No. | 1650550-25-6 | Cat. No. | BCP26166 |
| Name | Enasidenib mesylate | ||
| Synonyms | AG-221 mesylate; AG 221 mesylate; AG221 mesylate; | ||
| Formula | C20H21F6N7O4S | M. Wt | 569.48 |
| Description | Enasidenib mesylate is a first-in-class, oral, potent, reversible, selective inhibitor of the IDH2 mutant enzymes indicated for the treatment of adult patients with replased or refractory acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation. | ||
| Pathways | Protease/Metabolic Enzyme | ||
| Targets | IDH | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.